Package Leaflet: Information for the User
Pregabalin Sandoz 25mg hard capsules EFG
Pregabalin Sandoz 50mg hard capsules EFG
Pregabalin Sandoz 75mg hard capsules EFG
Pregabalin Sandoz 100mg hard capsules EFG
Pregabalin Sandoz 150mg hard capsules EFG
Pregabalin Sandoz 200mg hard capsules EFG
Pregabalin Sandoz 225mg hard capsules EFG
Pregabalin Sandoz 300mg hard capsules EFG
pregabalin
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Pregabalin Sandoz belongs to a group of medicines used to treat epilepsy, neuropathic pain, and generalized anxiety disorder (GAD) in adults.
Peripheral and central neuropathic pain:Pregabalin Sandoz is used to treat long-standing pain caused by nerve damage. There are several diseases that can cause peripheral neuropathic pain, such as diabetes or shingles. The feeling of pain can be described as heat, burning, throbbing, shooting, stabbing, sharp, spasms, continuous, tingling, numbness, and a feeling of pins and needles. Peripheral and central neuropathic pain may also be associated with mood changes, sleep disturbances, fatigue (tiredness), and can have an impact on physical and social activity and overall quality of life.
Epilepsy:Pregabalin Sandoz is used to treat certain types of epilepsy (partial seizures with or without secondary generalization) in adults. Your doctor will prescribe Pregabalin Sandoz for you to treat epilepsy when your current treatment does not control your condition. You should take Pregabalin Sandoz in addition to your current treatment. Pregabalin Sandoz should not be taken alone but should always be used in combination with other anti-epileptic treatments.
Generalized anxiety disorder:Pregabalin Sandoz is used to treat generalized anxiety disorder (GAD). The symptoms of GAD are prolonged and excessive anxiety and worry that is difficult to control. GAD can also cause restlessness or feeling on edge or nervous or irritable, being easily fatigued, having difficulty concentrating or feeling like your mind goes blank, sleep disturbances. This is different from the stresses and strains of everyday life.
Do not take Pregabalin Sandoz
Warnings and precautions
Talk to your doctor or pharmacist before taking Pregabalin Sandoz.
Dependence
Some people may become dependent on Pregabalin Sandoz (need to keep taking the medicine). They may have withdrawal effects when they stop taking Pregabalin Sandoz (see section 3, “How to take Pregabalin Sandoz” and “If you stop taking Pregabalin Sandoz”). If you are concerned that you may become dependent on Pregabalin Sandoz, it is important that you talk to your doctor.
If you notice any of the following signs while taking Pregabalin Sandoz, it could be a sign that you have become dependent:
If you notice any of these signs, talk to your doctor to discuss the best care plan for you, including when it is appropriate to stop treatment and how to do it safely.
Children and adolescents
The safety and efficacy in children and adolescents (under 18 years) have not been established, so pregabalin should not be used in this age group.
Other medicines and Pregabalin Sandoz
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Pregabalin Sandoz and certain medicines may affect each other (interactions). When Pregabalin Sandoz is taken with certain medicines that have sedative effects (including opioids), these effects may be enhanced, which may lead to respiratory failure, coma, and death. The degree of dizziness, somnolence, and decreased concentration may increase if Pregabalin Sandoz is taken with other medicines that contain:
Oxycodone - (used as a pain reliever)
Lorazepam - (used to treat anxiety)
Alcohol
Pregabalin Sandoz can be taken with oral contraceptives.
Taking Pregabalin Sandoz with food, drinks, and alcohol
Pregabalin Sandoz capsules can be taken with or without food.
It is advised not to drink alcohol during treatment with Pregabalin Sandoz.
Pregnancy and breastfeeding
Do not take Pregabalin Sandoz during pregnancy or breastfeeding, unless your doctor has told you to. The use of pregabalin during the first 3 months of pregnancy may cause congenital malformations in the fetus that require medical treatment. In a study that reviewed data from women in Nordic countries who took pregabalin during the first 3 months of pregnancy, 6 babies out of 100 had such congenital malformations. This compares to 4 babies out of 100 born to women not treated with pregabalin in the study. There have been reports of malformations of the face (cleft lip and palate), eyes, nervous system (including the brain), kidneys, and genitals.
An effective contraceptive method should be used in women of childbearing age. If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Driving and using machines
Pregabalin Sandoz may cause dizziness, somnolence, and decreased concentration. Do not drive, operate heavy machinery, or engage in other potentially hazardous activities until you know whether this medicine affects your ability to perform these activities.
Take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist. Do not take more medicine than prescribed.
Your doctor will determine the dose that is right for you.
Pregabalin Sandoz is for oral use only.
Peripheral and central neuropathic pain, epilepsy, or generalized anxiety disorder:
Your doctor will tell you to take Pregabalin Sandoz either twice or three times a day. For twice-daily dosing, take Pregabalin Sandoz once in the morning and once in the evening, approximately at the same time every day.
For three-times-daily dosing, take Pregabalin Sandoz in the morning, at noon, and in the evening, approximately at the same time every day.
If you think that the effect of Pregabalin Sandoz is too strong or too weak, talk to your doctor or pharmacist.
If you are an elderly patient (over 65 years old), you should take Pregabalin Sandoz normally, except if you have kidney problems.
Your doctor may prescribe a different dosing regimen or different doses if you have kidney problems.
Swallow the capsule whole with water.
Continue taking Pregabalin Sandoz until your doctor tells you to stop.
If you take more Pregabalin Sandoz than you should
Call your doctor or go to the nearest emergency department immediately. Take the pack or bottle of Pregabalin Sandoz capsules with you. As a result of taking more Pregabalin Sandoz than you should, you may feel drowsy, confused, agitated, or restless. Seizures and loss of consciousness (coma) have also been reported.
If you forget to take Pregabalin Sandoz
It is important that you take the capsules of Pregabalin Sandoz regularly at the same time each day. If you forget to take a dose, take it as soon as you remember, unless it is time for your next dose. In that case, continue with your next dose as usual. Do not take a double dose to make up for forgotten doses.
If you stop taking Pregabalin Sandoz
Do not stop taking Pregabalin Sandoz suddenly. If you want to stop taking Pregabalin Sandoz, talk to your doctor first. He will tell you how to do it. If you are going to stop treatment, it should be done gradually over a minimum of one week.
Once you have finished short- or long-term treatment with Pregabalin Sandoz, you should be aware that you may experience certain side effects, called withdrawal effects. These effects include sleep problems, headache, nausea, feeling anxious, diarrhea, flu-like symptoms, seizures, nervousness, thoughts of self-harm or suicide, depression, pain, sweating, and dizziness. These effects may occur more frequently or severely if you have been taking Pregabalin Sandoz for a longer period. If you experience withdrawal effects, you should contact your doctor.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Very Common: may affect more than 1 in 10 people
Dizziness, drowsiness, headache
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very Rare: may affect up to 1 in 10,000 people
Frequency Not Known: cannot be estimated from the available data
Once you have finished a short or long-term treatment with Pregabalina Sandoz, you should know that you may experience certain adverse effects, called withdrawal effects (see "If you stop treatment with Pregabalina Sandoz")
If you experience swelling in the face or tongue, or if your skin turns red and has blisters or peeling, you should seek medical attention immediately
Certain adverse effects, such as drowsiness, may be more frequent since patients with spinal cord injury may be taking other medications to treat, for example, pain or spasticity (stiff or rigid muscles), with adverse effects similar to those of Pregabalina, so the intensity of these effects may increase when taken together
The following adverse reaction has been reported in post-marketing experience: difficulty breathing, shallow breathing
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine
Keep this medicine out of the sight and reach of children
Do not use this medicine after the expiration date that appears on the blister, packaging, or box after CAD/EXP. The expiration date is the last day of the month indicated
Do not store above 25°C
High-density polyethylene bottles: use within 6 months after first opening
Medicines should not be thrown away through wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment
Composition of Pregabalina Sandoz
Appearance of the Product and Package Contents
25 mg capsules | Light brownish-yellow opaque cap and body, capsule size 4 (14.3 mm x 5.3 mm), filled with white to almost white powder |
50 mg capsules | Light yellow opaque cap and body, capsule size 3 (15.9 mm x 5.8 mm), filled with white to almost white powder |
75 mg capsules | Red opaque cap and white opaque body, capsule size 4 (14.3 mm x 5.3 mm), filled with white to almost white powder |
100 mg capsules | Red opaque cap and body, capsule size 3 (15.9 mm x 5.8 mm), filled with white to almost white powder |
150 mg capsules | White opaque cap and body, capsule size 2 (18.0 mm x 6.4 mm), filled with white to almost white powder |
200 mg capsules | Pale orange opaque cap and body, capsule size 1 (19.4 mm x 6.9 mm), filled with white to almost white powder |
225 mg capsules | Pale orange opaque cap and white opaque body, capsule size 1 (19.4 mm x 6.9 mm), filled with white to almost white powder |
300 mg capsules | Red opaque cap and light brownish-yellow opaque body, capsule size 0 (21.7 mm x 7.6 mm), filled with white to almost white powder |
Pregabalina Sandoz is available in the following presentations:
PVC/PVDC//Aluminum blisters packaged in a box
Unit-dose PVC/PVDC//Aluminum blisters packaged in a box
High-density polyethylene bottle with a polypropylene screw cap packaged in a box
25 mg capsules:
Blister packs containing 14, 28, 56, 70, 84, 100, or 120 hard capsules
Unit-dose blister packs containing 56 x 1, 84 x 1, or 100 x 1 hard capsules
High-density polyethylene bottles containing 200 hard capsules
50 mg capsules:
Blister packs containing 14, 21, 28, 56, 84, or 100 hard capsules
Unit-dose blister packs containing 84 x 1 hard capsules
High-density polyethylene bottles containing 200 hard capsules
75 mg capsules:
Blister packs containing 14, 21, 28, 56, 70, 84, 100, or 120 hard capsules
Unit-dose blister packs containing 14 x 1, 56 x 1, 84 x 1, 100 x 1, or 210 x 1 (3 x 70) hard capsules
High-density polyethylene bottles containing 100, 200, or 250 hard capsules
100 mg capsules:
Blister packs containing 14, 21, 28, 56, 84, or 100 hard capsules
Unit-dose blister packs containing 84 x 1 or 100 x 1 hard capsules
150 mg capsules:
Blister packs containing 14, 21, 28, 56, 70, 84, 100, or 120 hard capsules
Unit-dose blister packs containing 56 x 1, 84 x 1, 100 x 1, or 210 x 1 (3 x 70) hard capsules
High-density polyethylene bottles containing 100, 200, or 250 hard capsules
200 mg capsules:
Blister packs containing 21, 28, 84, or 100 hard capsules
Unit-dose blister packs containing 84 x 1 or 100 x 1 hard capsules
225 mg capsules:
Blister packs containing 14, 56, 70, 84, 100, or 120 hard capsules
300 mg capsules:
Blister packs containing 14, 21, 28, 56, 70, 84 (2 x 42), 100, 100 (2 x 50), or 120 (2 x 60) hard capsules
Unit-dose blister packs containing 56 x 1, 84 x 1 (2 x 42), 100 x 1, 100 x 1 (2 x 50), or 210 x 1 (3 x 70) hard capsules
High-density polyethylene bottles containing 100, 200, or 250 hard capsules
Not all pack sizes may be marketed
Marketing Authorization Holder
Sandoz GmbH, Biochemiestrasse 10, A-6250 Kundl, Austria
Manufacturer
Lek Pharmaceuticals d.d.
Verovškova, 57
SLO-1526 Ljubljana
Slovenia
or
Salutas Pharma GmbH
Otto-von-Guericke Allee 1
39179 Barleben
Germany
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Belgium Sandoz nv/sa Medialaan 40 B-1800 Vilvoorde Tel: +32 2 722 97 97 regaff.belgium@sandoz.com | Lithuania Sandoz Pharmaceuticals d.d. filialas Šeimyniškiu 3A, LT 09312 Vilnius Tel: +370 5 26 36 037 Info.lithuania@sandoz.com |
Luxembourg Sandoz nv/sa Medialaan 40 B-1800 Vilvoorde Tel: +32 2 722 97 97 regaff.belgium@sandoz.com | |
Czech Republic Sandoz s.r.o. Na Pankráci 1724/129 CZ-140 00 Praha 4 - Nusle Tel: +420 225 775 111 office.cz@sandoz.com | Hungary Sandoz Hungária Kft. Tel: +36 1 430 2890 |
Denmark Sandoz A/S Edvard Thomsens Vej 14 DK-2300 København S Denmark Tel: +45 6395 1000 info.danmark@sandoz.com | Malta Sandoz Pharmaceuticals d.d. Verovskova 57, SI-1000 Ljubljana Slovenia Tel: +356 21222872 |
Germany Hexal AG Industriestrasse 25 D-83607 Holzkirchen Tel: +49 8024 908 0 Email: service@hexal.com | Netherlands Sandoz B.V. Veluwezoom 22 NL-1327 AH Almere Tel: +31 36 5241600 info.sandoz-nl@sandoz.com |
Estonia Sandoz d.d. Eesti filiaal Pärnu mnt105 EE-11312 Tallinn Tel: +372 665 2400 info.ee@sandoz.com | Norway Sandoz A/S Edvard Thomsens Vej 14 DK-2300 København S Denmark Tel: +45 6395 1000 Info.danmark@sandoz.com |
Greece Novartis (Hellas) A.E.B.E. Tel: +30 210 281 17 12 | Austria Sandoz GmbH Biochemiestr. 10 A-6250 Kundl Tel: +43 5338 2000 |
Spain Sandoz Farmacéutica, S.A. Centro empresarial Parque Norte Edificio Roble C/Serrano Galvache, N°56 28033 Madrid Spain Tel: +34 900 456 856 registros.spain@sandoz.com | Poland Sandoz Polska Sp. z o.o. ul. Domaniewska 50C 02-672 Warszawa Tel: +48 22 209 70 00 biuro.pl@sandoz.com |
France Sandoz SAS 49 avenue Georges Pompidou F-92593 Levallois-Perret Cedex Tel: +33 1 4964 4800 | Portugal Sandoz Farmacêutica Lda. Phone: +351 21 196 40 00 |
Croatia Sandoz d.o.o. Maksimirska 120 10000 Zagreb Tel: +385 1 2353111 email: upit.croatia@sandoz.com | Romania Sandoz S.R.L. Str. Livezeni nr.7A, 540472 Târgu Mures +40 21 4075160 |
Ireland Rowex Ltd., Bantry, Co. Cork, Ireland P75 V009 Tel: +353 27 50077 email: reg@rowa-pharma.ie | Slovenia Lek farmacevtska družba d.d. Tel: +386 1 580 21 11 |
Iceland Sandoz A/S Edvard Thomsens Vej 14 DK-2300 København S Denmark Tel: +45 6395 1000 Info.danmark@sandoz.com | Slovakia Sandoz d.d. organizacná zložka Žižkova 22B SK-811 02 Bratislava Tel: +421 2 50 706 111 |
Italy Sandoz S.p.A Largo Umberto Boccioni 1 I - 21040 Origgio/VA Tel: +39 02 96541 | Finland Sandoz A/S Edvard Thomsens Vej 14 DK-2300 Kööpenhamina S Denmark Tel: +358 010 6133 400 Info.suomi@sandoz.com |
Cyprus Sandoz Pharmaceuticals d.d. Verovskova 57, SI-1000 Ljubljana Slovenia Tel: +357 22 69 0690 | Sweden Sandoz A/S Edvard Thomsens Vej 14 DK-2300 Köpenhamn S Denmark Tel: +45 6395 1000 Info.sverige@sandoz.com |
Latvia Sandoz d..d Latvia filiale K.Valdemara iela 33-29 Riga, LV1010 Tel: +371 67892006 | United Kingdom(Northern Ireland) Sandoz GmbH Biochemiestr. 10 A-6250 Kundl Tel: +43 5338 2000 |
Date of the Last Revision of this Leaflet:June 2023
Detailed information about this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu
The average price of PREGABALIN SANDOZ 100 mg HARD CAPSULES in October, 2025 is around 29.41 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.